Health
Chinese COVID vaccine candidate based on inactivated virus appears safe, induces immune response, study finds – Medical Xpress
Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today…
Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today in The Lancet Infectious Diseases journal, finding the formulation appears safe and induces an antibody response in healthy volunteers aged 18 to 59 years.
Antibody responses could be induced within 28 days of the first immunisation, by giving two doses of the vaccine candidate 14 days apart.
The study also identifies the optimum dose…
-
General17 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News17 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General19 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
General24 hours agoCrowe toasts talkback titan for platforming ‘voiceless’